Suppr超能文献

相似文献

1
Gain of glycosylation: a new pathomechanism of myelin protein zero mutations.
Ann Neurol. 2012 Mar;71(3):427-31. doi: 10.1002/ana.22695.
2
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations.
Hum Mol Genet. 2008 Jul 1;17(13):1877-89. doi: 10.1093/hmg/ddn083. Epub 2008 Mar 12.
4
Genetic epidemiology of Charcot-Marie-Tooth disease.
Acta Neurol Scand Suppl. 2012(193):iv-22. doi: 10.1111/ane.12013.
8
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice.
J Neurosci. 2006 Feb 22;26(8):2358-68. doi: 10.1523/JNEUROSCI.3819-05.2006.
10
Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero.
Acta Neuropathol. 2000 Sep;100(3):299-304. doi: 10.1007/s004019900175.

引用本文的文献

3
Emerging cellular themes in leukodystrophies.
Front Cell Dev Biol. 2022 Aug 8;10:902261. doi: 10.3389/fcell.2022.902261. eCollection 2022.
4
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism.
Hum Mol Genet. 2022 Dec 16;31(24):4255-4274. doi: 10.1093/hmg/ddac170.
5
Mechanisms and Treatments in Demyelinating CMT.
Neurotherapeutics. 2021 Oct;18(4):2236-2268. doi: 10.1007/s13311-021-01145-z. Epub 2021 Nov 8.
6
Animal Models as a Tool to Design Therapeutical Strategies for CMT-like Hereditary Neuropathies.
Brain Sci. 2021 Sep 18;11(9):1237. doi: 10.3390/brainsci11091237.
7
How Does Protein Zero Assemble Compact Myelin?
Cells. 2020 Aug 4;9(8):1832. doi: 10.3390/cells9081832.
8
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype.
J Neurol. 2019 Nov;266(11):2629-2645. doi: 10.1007/s00415-019-09453-3. Epub 2019 Jul 5.
9
Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B.
Ann Clin Transl Neurol. 2018 Mar 10;5(4):445-455. doi: 10.1002/acn3.543. eCollection 2018 Apr.

本文引用的文献

1
Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination.
Science. 2010 Jun 11;328(5984):1415-8. doi: 10.1126/science.1187735. Epub 2010 May 6.
3
Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies.
Eur J Hum Genet. 2009 Sep;17(9):1129-34. doi: 10.1038/ejhg.2009.37. Epub 2009 Mar 18.
4
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations.
Hum Mol Genet. 2008 Jul 1;17(13):1877-89. doi: 10.1093/hmg/ddn083. Epub 2008 Mar 12.
5
Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system.
Mol Neurobiol. 2007 Jun;35(3):308-16. doi: 10.1007/s12035-007-0031-0.
6
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice.
J Neurosci. 2006 Feb 22;26(8):2358-68. doi: 10.1523/JNEUROSCI.3819-05.2006.
7
Peripheral neuropathies caused by mutations in the myelin protein zero.
J Neurol Sci. 2006 Mar 15;242(1-2):55-66. doi: 10.1016/j.jns.2005.11.015. Epub 2006 Jan 18.
8
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations.
Nat Genet. 2005 Jul;37(7):692-700. doi: 10.1038/ng1581. Epub 2005 May 29.
9
Conformational defects slow Golgi exit, block oligomerization, and reduce raft affinity of caveolin-1 mutant proteins.
Mol Biol Cell. 2004 Oct;15(10):4556-67. doi: 10.1091/mbc.e04-06-0480. Epub 2004 Aug 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验